GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Pparg | multiple interactions | EXP | | 6480464 | CTD | [Celecoxib co-treated with docetaxel] results in increased expression of PPARG protein | PMID:16052515 | Pparg | affects localization | ISO | PPARG (Homo sapiens) | 6480464 | CTD | Celecoxib affects the localization of PPARG protein | PMID:23943857 | Pparg | increases expression | ISO | PPARG (Homo sapiens) | 6480464 | CTD | Celecoxib results in increased expression of PPARG mRNA; Celecoxib results in increased expression of PPARG protein | PMID:23943857 | Pparg | multiple interactions | ISO | Pparg (Rattus norvegicus) | 6480464 | CTD | Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] | PMID:19247274 | Pparg | multiple interactions | ISO | PPARG (Homo sapiens) | 6480464 | CTD | 2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein]; [Celecoxib results in decreased activity of and results in decreased expression of PTGS2 protein] which results in increased expression of PPARG; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Celecoxib affects the localization of PPARG protein] | PMID:19522023 PMID:23943857 | |
Go Back to source page | Continue to Ontology report |